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Since the pioneering work of 
Everett and Sawyer, the idea that 
pituitary gonadotrophins provide 
the critical timing cue for ovulation 
has remained unquestioned [1]. It 
is widely accepted that the timing 
of ovulation depends entirely on 
the timing of luteinizing hormone 
(LH) secretion, itself driven by 
neuroendocrine releasing factors 
controlled by the circadian clock in 
the suprachiasmatic nucleus (SCN) 
[2,3]. As a consequence, there has 
been little investigation of a role for 
the ovary in this process. However, 
we and others have demonstrated 
the presence of endogenous 
circadian clocks in the rat ovary [4–6]. 
Here we describe a circadian rhythm 
of ovarian sensitivity to LH that 
determines the ovulatory response 
to gonadotrophins. It is plausible 
that the circadian clock in the ovary 
may set the responsiveness of the 
ovarian follicle to the LH surge. Our 
results significantly alter the classic 
view that gonadotrophins provide the 
only timing cue for ovulation. They 
suggest that the ovary itself plays a 
major role in the process and provide 
a new perspective that will inform 
future research on infertility and 
ovarian physiology. 
We blocked endogenous 
gonadotrophin secretion and 
assessed ovulation in response to 
timed exogenous LH treatments as a 
measure of phasic ovarian sensitivity. 
We suppressed endogenous 
gonadotrophin secretion with 
cetrorelix pamoate depot (CET), a 
highly selective and long-lasting 
GnRH receptor antagonist [7] (see 
Figure S1A in supplemental data, 
published with this article online). We 
first analyzed the pattern of ovarian 
sensitivity between the evening 
of diestrus and the afternoon of 
proestrus. Cycling rats maintained 
under a 12:12 L:D cycle (lights 
on 05:00h) were injected at ZT11 
(Zeitgeber Time; ZT0 = lights on) on 
diestrus with CET (1 mg/0.1 m; i.m.).  
Beginning 7h later, groups of rats were treated with equine LH (eLH; 
600 IU; see Figure S1B) at 3h 
intervals during the subsequent 
18h (ZT18 and 21 on diestrus; 
ZT0, 3, 6, 9 and 12 on proestrus). 
Rats injected with eLH during the 
middle of the dark portion of the L:
D cycle on diestrus ovulated more 
frequently and produced significantly 
more oocytes than did animals 
injected during the middle of the day 
(Figure 1A). The number of oocytes 
released between ZT6 and ZT9 
increased and remained elevated 
through the end of the light phase 
on proestrus (ZT12; Figure 1A). 
Separate groups of cycling rats 
maintained under the same light–dark 
cycle were injected with CET at 
ZT5 on proestrus. Beginning 7h 
after CET treatment, groups of rats 
were treated with equine LH at 3h 
intervals during the subsequent 
21h. Rats injected with eLH during 
the dark portion of the L:D cycle on 
proestrus ovulated more frequently 
and produced significantly more 
oocytes compared with animals 
injected during the light portion of 
estrus (ZT12–21 vs. ZT24–9; p < 
0.001). The most robust response 
to eLH was seen during the middle 
of the night on proestrus; the 
smallest response was seen 9h into 
the light portion of the L:D cycle 
on estrus (Figure 1A). A multiple 
harmonic regression analysis (see 
supplemental methods) verified the 
significance of the diurnal rhythms of 
ovarian responsiveness on diestrus 
(F = 6.23, p < 0.01; Figure 1A inset 
on the left) and proestrus (F = 36.48, 
p < 0.001; Figure 1A inset on the 
right). Regardless of treatment time, 
animals receiving CET treatment 
on either day failed to ovulate in 
response to saline. Serum LH level 
was significantly reduced in all of the 
CET-treated animals when compared 
with serum from animals treated 
with saline vehicle (p < 0.001; see 
Figure S1A). 
To determine if the diurnal 
rhythm of eLH-induced ovulation 
is endogenous and circadian we 
replicated a portion of our initial 
experiment with rats maintained in 
constant dim light (dimLL). Rats in 
dimLL displayed clear free-running 
circadian rhythms of activity and a 
strong rhythm of ovarian sensitivity 
to eLH treatment (Figure 1B). Six of 
seven rats ovulated in response to 
eLH treatment during the subjective night at CT12 (CT12 = activity onset); 
14 ± 2.58 oocytes/ovulation) and 5/5 
rats ovulated following treatment at 
CT18 (14 ± 1.34 oocytes/ovulation). 
Rats treated during the subjective 
night ovulated more frequently 
and produced significantly more 
oocytes/ovulation than animals 
treated during the subjective day 
(CT0, 3/6 rats ovulated, 3.7 ± 1.94 
oocytes/ovulation; CT6, 3/7 rats 
ovulated, 1.9 ± 1.12 oocytes/
ovulation; p < 0.01 vs. CT12 and 
CT18). Multiple harmonic regression 
analysis validated the robustness of 
this free- running circadian rhythm of 
ovarian sensitivity (inset Figure 1B; 
F = 18.14, p < 0.001). Animals treated 
with CET and injected with saline 
failed to ovulate, regardless of 
treatment phase. 
Our data suggest that a circadian 
clock drives the sensitivity of the 
ovary to LH and thus participates in 
the timing of ovulation. The rhythm of 
ovarian sensitivity may be driven from 
outside the ovary by, for example, 
rhythms of circulating melatonin, 
glucocorticoids, thyroid hormones 
or other endocrine or neural factors. 
Alternatively, the oscillator may be 
located in the ovary. This is a strong 
possibility since we know that the 
ovary has its own circadian clock [6]. 
If the ovarian clock plays a role in the 
timing of ovulation, what mechanism 
might underlie its influence? One 
(of several) possibilities involves 
the regulation of prostanoid levels. 
A significant step in the response 
of the ovarian granulosa cell to 
LH is the increase in the level of 
prostaglandin E2 and prostaglandin 
F2α, which together mediate the 
inflammatory response preceding 
follicular rupture [8]. The rate-limiting 
step in prostaglandin (PG) synthesis 
is the activity of cyclooxygenase-2 
(COX2). COX2 expression is regulated 
by E-box promoter elements which 
are targets of the CLOCK–BMAL1 
transactivator complex [9,10]. 
Further, the timing of COX2 gene 
expression is highly conserved. In 
several species COX2 mRNA begins 
to increase approximately 10h before 
ovulation [8]. CLOCK–BMAL1 binding 
to the COX2 promoter may regulate 
the timing of COX2 expression on the 
day of ovulation. Thus an increase in 
COX2 and PG activity in the ovary, in 
anticipation of the LH surge, might 
establish a critical period for follicular 
rupture.
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Figure 1. Injections of eLH after cetrorelix-induced suppression of LH secretion reveal a circadian rhythm of ovarian sensitivity. 
(A) Groups of rats housed under a 12:12 L:D cycle were injected at ZT11 on diestrus or ZT5 on proestrus with Cetrorelix pamoate depot (1 mg/0.1 
ml; i.m.) followed by either eLH (600 IU in 0.2 ml sterile saline i.p.; black diamonds for diestrus; black circles for proestrus) or saline vehicle (0.2 
ml; open gray circles for both diestrus and proestrus) every 3h beginning at ZT18 on diestrus and ZT12 on proestrus. Regardless of estrous cycle 
day, animals injected with eLH during the night ovulated more frequently and produced significantly more oocytes/ovulation. The discontinuity 
at ZT12 on proestrus is a consequence of a decline in the number of mature and responsive follicles in the animals injected at ZT11 on diestrus 
following 25h without LH/FSH support. Treatment with sterile saline failed to produce ovulation regardless of injection time. Asterisks indicate 
a significant increase in mean oocyte number above basal level (ZT6 on proestrus; ZT9 on estrus) within the eLH treated group as a function 
of time. The open and solid bars at the top of the figure indicate the light and dark portions of the L:D cycle. The dashed black line represents 
a non-linear regression generated with a fourth-order polynomial. The arrowheads on the abscissa indicate the time of CET treatment. Inset 
graphs: curves generated by a CircWave multiple harmonic regression analysis (left; diestrus, right; proestrus; see supplementary experimental 
methods). Horizontal grid lines are included to emphasize the amplitude of the harmonic regressions. (B) Animals were injected at CT5 on proe-
strus with Cetrorelix pamoate depot (1 mg/0.1 ml; i.m.) followed by either eLH (600 IU i.p.; solid black circles) or sterile saline (data not shown) 
at one of 4 timepoints beginning at CT12 on proestrus. Treatment with sterile saline failed to produce ovulation regardless of injection time. 
Asterisks indicate a significant increase in mean oocyte number above basal level (ZT6) within the eLH treated group and between treatments 
as a function of time. The solid gray background indicates that animals were maintained under constant dim light. The light-gray data points and 
dotted curve are replicated from Figure 1A (ZT12 ~ CT12) to emphasize the similarity of the results in dimLL to those in L:D. The dashed black 
line represents a non-linear regression generated with a fourth-order polynomial. The black arrowhead indicates the time of CET-treatment.  In 
Figures 1A and B, data were considered significant at p < 0.05 and are presented as mean ± SEM. See Table S1 for the percentage and absolute 
numbers of rats that ovulated at each time point, as well as the mean number of eggs produced by each animal. Inset graph: Curve generated 
by same method as in (A).Supplemental Data
Supplemental data are available at http://www.
current-biology.com/supplemental/S0960-
9822(10)00088-6.
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